Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.
about
Biological predictors of pharmacological therapy in anxiety disordersBiological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.The 5-HTTLPR confers susceptibility to anorexia nervosa in Han Chinese: evidence from a case-control and family-based study.Epigenetic Modulation of Mood Disorders.Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review.Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder.Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.Biological markers of generalized anxiety disorder.Genetics of generalized anxiety disorder and related traits.
P2860
Q26781100-D9472CBF-2F7E-4AA4-A572-5AA533D47E26Q31114020-D0C5D281-1183-4163-AF0D-D61EFF05A075Q34453981-13D3DBDA-6716-47BC-AC95-DCF5BF6A8EF3Q34473840-AA452F17-1941-41ED-A817-FA5AB1B7566DQ35192252-E60AFD4C-FE87-4567-8E6A-1A9A28BB810BQ36737217-DAFE29CC-A17E-4D89-B39E-2A94EC71E367Q38168858-EE51D1BE-0A2E-4603-B705-C72AEA93D7D4Q38243174-86A46379-9B0D-40AD-87CE-BB057A421912Q38357402-B5CD966F-41B3-414A-8E26-82B802A54C0DQ38718213-200BC61D-0F78-4C70-89C4-769BFF701E2BQ39211780-BE2FE327-C779-48C5-82A6-C42AB969C508Q39422188-1A3248CA-08C2-42EB-AB2E-7D4CE9FB3CF3Q41535712-3ACF1049-0001-4F4D-8A0B-401550FBDF4AQ41535721-64A19516-2782-4ABD-B0E3-B99634F71934
P2860
Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Interaction between polymorphi ...... generalized anxiety disorder.
@en
Interaction between polymorphisms in serotonin transporter
@nl
type
label
Interaction between polymorphi ...... generalized anxiety disorder.
@en
Interaction between polymorphisms in serotonin transporter
@nl
prefLabel
Interaction between polymorphi ...... generalized anxiety disorder.
@en
Interaction between polymorphisms in serotonin transporter
@nl
P2860
P356
P1476
Interaction between polymorphi ...... generalized anxiety disorder.
@en
P2093
P2860
P2888
P304
P356
10.1038/TPJ.2012.33
P577
2012-08-21T00:00:00Z
P6179
1002341411